TAB. MELKERAN 2 MG
Product Description
RMPL Pharma LLP
-
IN -
2018On CPHI since
-
1 - 24Employees
Company types
Categories
Specifications
RMPL Pharma LLP
-
IN
-
2018On CPHI since
-
1 - 24Employees
Company types
More Products from RMPL Pharma LLP (2)
-
Product INJ. MELKERAN 50 MG
- PALLIATIVE TREATMENT OF MULIPLE MYELOMA.- PALLIATION OF NON - RESECTABLE EPITHELIAL CARCINOMA OF THE OVARY . -
Product INJ.LEUCOVORIN CALCIUM 50 MG
- AN ACTIVE METABOLITE OF FOLIC ACID ( ALSO CALLED FOLINIC ACID AND CICTROVORUM FACTOR ), WHICH DOSE NOT REQUIRE METABOLISM BY DIHYDROFOLATE REDUCTASE , THE MOLECULAR TARGET OF FOLATE ANTAGONIST- TYPE CHEMOTHERAPEUTIC DRUGS.
RMPL Pharma LLP resources (1)
-
Brochure RMPL PHARMA LLP.
The primary goal of RMPL PHARMA LLP. is to supply our consumers with pharmaceutical products by providing assurance regarding their performance safety, value and consistency. The commitment to quality is well rooted in corporate values of our company and is very essential to our continuous development & success.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance